L364,718 antagonizes the cholecystokinin-induced suppression of locomotor activity.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  1989-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0091-3057(89)90401-2PMID 2587606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The cholecystokinin receptor antagonist L364,718 increases food intake in the rat by attenuation of the action of endogenous cholecystokinin

  1988cited by this paper
• Potency of L-364,718 as an antagonist of the behavioral effects of peripherally administered cholecystokinin.

  1988cited by this paper
• In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.

  1987cited by this paper
• A behavioral pharmacological study on CCK-8 related peptides in mice.

  1986cited by this paper
• Cholecystokinin-induced suppression of locomotion is attenuated in capsaicin pretreated rats.

  1986cited by this paper
• Behavioral effect of cholecystokinin octapeptide in vagotomized rats.

  1986cited by this paper
• Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.

  1986cited by this paper
• Two brain cholecystokinin receptors: implications for behavioral actions.

  1986cited by this paper
• A Study of the Cerebral Cortex Cholecystokinin Receptor Using Two Radiolabelled Probes: Evidence for a Common CCK 8 and CCK 4 Cholecystokinin Receptor Binding Site

  1986cited by this paper
• Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.

  1986cited by this paper
• Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.

  1986cited by this paper
• A Microcomputer System for Long-term Monitoring and Analysis of Locomotor Activity

  1985cited by this paper
• Afferent axons in abdominal vagus mediate satiety effect of cholecystokinin in rats.

  1985cited by this paper
• Lack of Competition between Two Reputed Peripheral Cholecystokinin Receptor Antagonists for Central Cholecystokinin Binding Sites

  1985cited by this paper
• Do antagonists of pancreatic cholecystokinin receptors interact with central nervous system cholecystokinin receptors?

  1985cited by this paper
• Brain CCK receptors are structurally distinct from pancreas CCK receptors.

  1984cited by this paper
• Divergent effects of cholecystokinin, bombesin, and lithium on rat exploratory behaviors.

  1983cited by this paper
• Caerulfin and cholecystokinin octapeptide (CCK-8): Sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788

  1982cited by this paper
• Minireview. The ascent of cholecystokinin (CCK) - from gut to brain.

  1982cited by this paper
• The satiety effect of cholecystokinin: a progress report.

  1981cited by this paper
• Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8).

  1980cited by this paper
• Satiety effects of cholecystokinin and caerulein in rabbits.

  1978cited by this paper

• METABOLIC SIGNALS IN SLEEP REGULATION: THE ROLE OF CHOLECYSTOKININ

  2010cites this paper
• Neuroregulation of nonexercise activity thermogenesis and obesity resistance.

  2008cites this paper
• Neuroendocrine Control of Peripheral Metabolic Function

  2007cites this paper
• Neuropeptidergic Mediators of Spontaneous Physical Activity and Non-Exercise Activity Thermogenesis

  2007cites this paper
• Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse

  2005cites this paper
• New CCK2 agonists confirming the heterogeneity of CCK2 receptors: characterisation of BBL454

  2004cites this paper
• Cholecystokinin modulation of apomorphine- or amphetamine-induced stereotypy in rats: opposite effects.

  2001cites this paper
• Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.

  2000cites this paper
• Opposing effects of two CCK(B) agonists on the retrieval phase of a two-trial memory task after systemic injection in the rat.

  1999cites this paper
• SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. II. In vivo pharmacological characterization.

  1999cites this paper
• Pharmacological evaluation of IQM‐95,333, a highly selective CCKA receptor antagonist with anxiolytic‐like activity in animal models

  1997cites this paper
• Nitric oxide mediates caerulein-induced suppression of locomotor activity.

  1996cites this paper
• Subdiaphragmatic vagotomy does not prevent the anti-exploratory effect of caerulein in the elevated plus-maze.

  1994cites this paper
• Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats

  1994cites this paper
• Evidence for mnemotropic action of cholecystokinin fragments Boc-CCK-4 and CCK-8S.

  1994cites this paper
• Neurobehavioural effects of SR 27897, a selective cholecystokinin type A (CCK-A) receptor antagonist

  1993cites this paper
• Effects of CCK antagonists on CCK-induced suppression of locomotor activity in mice.

  1992cites this paper
• Scheduled running wheel activity indexes the specificity of pharmacological anorexia.

  1992cites this paper
• Type-A CCK receptors mediate the inhibition of food intake and activity by CCK-8 in 9- to 12-day-old rat pups.

  1991cites this paper
• Cholecystokinin antagonists.

  1991cites this paper
• Brain CCKA receptors mediate the colonic motor response to feeding in dogs.

  1991cites this paper
• Barrel rotation in rats induced by SMS 201-995: suppression by ceruletide.

  1990cites this paper